About Hangzhou Tigermed Consulting Company

Tiger Pharmaceuticals (stock code: 300347.SZ/3347.HK) is an industry-leading integrated biomedical R&D service platform, providing innovative R&D solutions spanning a full cycle for the global pharmaceutical and medical device industry. Through a comprehensive service system and top quality standards, we help the biomedical industry improve R&D efficiency, reduce R&D risks, ensure high-quality delivery of research projects, accelerate the marketization process of pharmaceutical products, and fulfill our promises to the industry and patients. The company is a contract research organization (CRO) focusing on providing professional services throughout the clinical trial process for new drug research and development. It provides comprehensive and comprehensive clinical research solutions for global pharmaceutical and medical device innovators, ensures research quality, reduces R&D risks, shortens R&D cycles, saves R&D expenses, and promotes the product marketization process, so that patients can use newer and better pharmaceuticals and medical products as soon as possible. The services provided by the company mainly include clinical trial technical services and clinical trial related services Business and laboratory services. Corporate honors: Eli Lilly Global Supplier Award, MSD Supplier Outstanding Service Award, Top 10 Listed Chinese Pharmaceutical Companies with the Most Investment Value, etc.